Related Experiment Video
Updated: Mar 10, 2026

07:50
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
2.5K
Cis-bifenthrin causes immunotoxicity in murine macrophages
Xia Wang1, Xingli Gao1, Bingnan He1
1College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China.
Chemosphere
|December 6, 2016
Summary
Synthetic pyrethroids like bifenthrin (BF) can harm human health. This study shows BF induces macrophage apoptosis and oxidative stress, potentially impairing immune responses. Further research is needed for risk assessment.
Area of Science:
- Toxicology
- Immunology
- Cell Biology
Background:
- Synthetic pyrethroids (SPs) are widely used insecticides.
- Bifenthrin (BF), an SP, exhibits potential neurotoxic, reproductive, hepatotoxic, and nephrotoxic effects.
- Limited data exists on BF's immunotoxicity and mechanisms.
Purpose of the Study:
- To investigate the immunotoxicity of cis-bifenthrin (cis-BF) on RAW 264.7 macrophages.
- To elucidate the underlying mechanisms of cis-BF-induced immunotoxicity.
Main Methods:
- Exposure of RAW 264.7 cells to varying concentrations of cis-BF.
- MTT assay to assess cell viability and apoptosis.
- Analysis of apoptosis-related gene expression (p53, caspase-3, Bcl-2).
- Measurement of reactive oxygen species (ROS) levels.
- Assessment of cytokine (IL-1β, IL-6, TNF-α, IFN-β) and oxidative stress gene expression.
Main Results:
- Cis-BF induced apoptosis in RAW 264.7 cells in a dose-dependent manner.
- Apoptosis involved upregulation of p53 and caspase-3, and downregulation of Bcl-2.
- Cis-BF caused oxidative stress, increasing ROS levels and dysregulating oxidative stress genes.
- BF inhibited LPS-induced pro-inflammatory cytokine (IL-1β, IL-6, TNF-α) and virus-induced IFN-β mRNA expression.
Conclusions:
- Cis-BF exhibits immunotoxicity towards macrophages.
- Mechanisms include apoptosis induction, oxidative stress, and suppression of inflammatory and antiviral responses.
- Findings highlight the need to consider immune dysfunction in cis-BF risk assessments.

